Xiaolin Liang
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Genetics top 5%
- BRCA gene mutations in cancer
Papers in ⓘ
-
- Breast Cancer Treatment Studies 12
- MicroRNA in disease regulation 7
- Co-authors
- Leslie Bernstein (24 shared papers)Jonine L. Bernstein (27 shared papers)Jed A. Fuhrman (2 shared papers)Rachel T. Noble (2 shared papers)Kathleen E. Malone (23 shared papers)Charles F. Lynch (23 shared papers)Patrick Concannon (16 shared papers)Marinela Capanu (10 shared papers)
- Journals
- Breast Cancer Research (7 papers)European Journal of Medicinal Chemistry (5 papers)Journal of Medicinal Chemistry (3 papers)BMJ Open (3 papers)Human Mutation (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaolin Liang
90 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 141
- Cancer Research 439
- Genetics 583
- Toxicology 68
- Oncology 366
- Organic Chemistry 357
Countries citing papers authored by Xiaolin Liang
This map shows the geographic impact of Xiaolin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Liang more than expected).
Fields of papers citing papers by Xiaolin Liang
This network shows the impact of papers produced by Xiaolin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Liang. The network helps show where Xiaolin Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolin Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 187 | |
| 2 | 2015 | 124 | |
| 3 | 2006 | 121 | |
| 4 | 2010 | 103 | |
| 5 | 2014 | 100 | |
| 6 | 2011 | 90 | |
| 7 | 2005 | 89 | |
| 8 | 2012 | 81 | |
| 9 | 2013 | 79 | |
| 10 | 2011 | 65 | |
| 11 | 2012 | 59 | |
| 12 | 2012 | 49 | |
| 13 | 2010 | 48 | |
| 14 | 2014 | 44 | |
| 15 | 2010 | 43 | |
| 16 | 2013 | 37 | |
| 17 | 2017 | 36 | |
| 18 | 2020 | 34 | |
| 19 | 2012 | 34 | |
| 20 | 2009 | 34 |
About Xiaolin Liang
Xiaolin Liang is a scholar working on Cancer Research, Toxicology, Hematology, Genetics and Oncology, having authored 98 papers that have together received 2.2k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (17 papers), Breast Cancer Treatment Studies (12 papers), Cancer Risks and Factors (10 papers), Acute Myeloid Leukemia Research (9 papers), Global Cancer Incidence and Screening (8 papers), MicroRNA in disease regulation (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Gut microbiota and health (6 papers). The work is most often cited by research in Cancer Research (439 citations), Genetics (583 citations), Toxicology (68 citations), Oncology (366 citations) and Organic Chemistry (357 citations). Xiaolin Liang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Leslie Bernstein, Jonine L. Bernstein, Jed A. Fuhrman, Rachel T. Noble, Kathleen E. Malone, Charles F. Lynch, Patrick Concannon, Marinela Capanu, Liang Ma and Jinying Chen. Their work appears in journals such as Breast Cancer Research, European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, BMJ Open and Human Mutation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.